Table 2.
Summary of Accrual, Attrition and Evaluable Cases within Randomized Groups by Cancer Center
| Study Status | Site #1 (Hackensack Univ) | Site #2 (Long Beach Med Ctr) | Site #3 (St. Jude) | Total |
|---|---|---|---|---|
|
| ||||
| Total Accrual | 71 | 46 | 126 | 243 |
|
| ||||
| Total Attrition (Lost) | 9 (13%) | 7 (15%) | 14 (11%) | 30 (12%) |
|
| ||||
| Total Evaluable | 62 (87%) | 39 (85%) | 112 (89%) | 213 (88%) |
| Low Risk | 19 | 12 | 41 | 72 |
| High Risk | 43 | 27 | 71 | 141 |
|
| ||||
| Evaluable EC Cases a | 29 (85%) | 19 (83%) | 54 (86%) | 102 (85%) |
|
| ||||
| Evaluable UC Cases b | 33 (89%) | 20 (87%) | 58 (92%) | 111 (90%) |
a
Enhanced care group or treatment.
b
Usual care group or comparison group.